Recap: Novozymes Q4 Earnings

Novozymes NVZMY reported its Q4 earnings results on Thursday, February 1, 2024 at 03:00 AM.

Here's what investors need to know about the announcement.

Novozymes missed estimated earnings by 18.18%, reporting an EPS of $0.36 versus an estimate of $0.44.

Revenue was up $58.13 million from the same period last year.

Last quarter the company beat on EPS by $0.07 which was followed by a 2.66% increase in the share price the next day.

Here's a look at Novozymes's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	0.42	0.42	0.44	0.41
EPS Actual	0.49	0.32	0.41	0.43
Revenue Estimate	634.28M	632.02M	662.60M	671.94M
Revenue Actual	650.51M	616.52M	666.31M	606.10M

To track all earnings releases for Novozymes visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar